tirzepatide ruling 2025 Navigating the FDA's New on Semaglutide and Mounjaro will remain off shortage

PLGA-quercetin nano-formulation inhibits cancer progression via mitochondrial dependent caspase-3,7 and independent foxO1 activation with concomitant PI3K/AKT suppression

The SELECT trial will assess whether subcutaneous semaglutide improves CV outcomes in obese or overweight patients without T2D

Understanding tirzepatide expiration and refrigeration requirements protects both your health and your investment

Sofwave is equally effective on the body, targeting loose skin on the arms, thighs, and abdomen, which are common areas of concern after weight loss

Earlier initiation is reshaping patient journeys: Patients are starting GLP1 therapy within weeks of diagnosis, underscoring the need for streamlined access pathways and payer alignment to reduce delays, especially in Medicare populations

This includes 4 weeks of medication depending on your evaluation and needs